Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Receivables (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Receivables for 10 consecutive years, with $55.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables rose 26.33% to $55.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $55.1 million, a 26.33% increase, with the full-year FY2025 number at $55.1 million, up 26.33% from a year prior.
  • Receivables was $55.1 million for Q4 2025 at Orthopediatrics, up from $51.3 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $55.1 million in Q4 2025 to a low of $16.6 million in Q1 2021.
  • A 5-year average of $33.8 million and a median of $34.9 million in 2023 define the central range for Receivables.
  • Peak YoY movement for Receivables: grew 3.95% in 2021, then surged 51.18% in 2022.
  • Orthopediatrics' Receivables stood at $19.2 million in 2021, then surged by 35.73% to $26.0 million in 2022, then skyrocketed by 37.69% to $35.9 million in 2023, then increased by 21.58% to $43.6 million in 2024, then increased by 26.33% to $55.1 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Receivables are $55.1 million (Q4 2025), $51.3 million (Q3 2025), and $53.8 million (Q2 2025).